Vitamin D and HIV infection: A review of the clinical evidence

Future Virology

Volumn 8, Issue 6, 2013, Pages 589-606

  Tafazoli, Ali ^a   Khalili, Hossein ^b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

AIDS; HIV; vitamin D

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; VITAMIN D;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CROSS-SECTIONAL STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 84878708472     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.13.40     Document Type: Review

References (106)

1. Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J. Clin. Virol. 50(3), 194-200 (2011).
2. Babameto G, Kotler DP. Malnutrition in HIV infection. Gastroenterol. Clin. North. Am. 26(2), 393-415 (1997).
3. Shahar E, Segal E, Rozen GS, et al. Vitamin D status in young HIV infected women of various ethnic origins: incidence of vitamin D deficiency and possible impact on bone density. Clin. Nutr. 2, 456-462 (2012).
4. Adeyemi OM, Agniel D, French AL, et al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J. Acquir. Immune Defic. Syndr. 57(3), 197-204 (2011).
5. Mehta S, Hunter DJ, Mugusi FM, et al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal Vitamin D status in Tanzania. J. Infect. Dis. 200(7), 1022-1030 (2009).
6. Conrado T, Miranda-Filho Dde B, Ximenes RA, et al. Vitamin D deficiency in HIV-infected women on antiretroviral therapy living in the tropics. J. Int. Assoc. Physicians AIDS Care (Chic.) 10(4), 239-245 (2011).
7. Stein EM, Yin MT, McMahon DJ, et al. Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos. Int. 22(2), 477-487 (2011).
8. Cervero M, Agud J, García-Lacalle C, et al. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy. AIDS Res. Hum. Retrovi. 28(9), 963-971 (2012).
9. Allavena C, Delpierre C, Cuzin L, et al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J. Antimicrob. Chemother. 67(9), 2222-2230 (2012).
10. Nansera D, Graziano FM, Friedman DJ, Bobbs MK, Jones AN, Hansen KE. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int. J. Tuberc. Lung Dis. 15(11), 1522-1527 (2011).
11. Vescini F, Cozzi-Lepri A, Borderi M, et al.; Icona Foundation Study Group. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J. Acquir. Immune Defic. Syndr. 58(2), 163-172 (2011).
12. Dao CN, Patel P, Overton ET, et al.; Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin. Infect. Dis. 52(3), 396-405 (2011).
13. Stephensen CB, Marquis GS, Kruzich LA, Douglas SD, Aldrovandi GM, Wilson CM. Vitamin D status in adolescents and young adults with HIV infection. Am. J. Clin. Nutr. 83(5), 1135-1141 (2006).
14. Haug CJ, Aukrust P, Haug E, Mørkrid L, Müller F, Frøland SS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J. Clin. Endocrinol. Metab. 83(11), 3832-3838 (1998).
15. Conesa-Botella A, Florence E, Lynen L, Colebunders R, Menten J, Moreno-Reyes R. Decrease of vitamin D concentration in patients with HIV infection on a non-nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res. Ther. 7, 40 (2010).
16. Etminani-Esfahani M, Khalili H, Soleimani N, et al. Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr. HIV Res. 10(2), 165-170 (2012).
17. Haug C, Müller F, Aukrust P, Frøland SS. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J. Infect. Dis. 169(4), 889-893 (1994).
18. Terrier B, Carrat F, Geri G, et al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis. J. Hepatol. 55(4), 756-761 (2011).
19. Ormesher B, Dhaliwal S, Nylen E, et al. Vitamin D deficiency is less common among HIV-infected African-American men than in a matched cohort. AIDS 25(9), 1237-1239 (2011).
20. Mueller NJ, Fux CA, Ledergerber B, et al.; Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 24(8), 1127-1134 (2010).
21. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al. Vitamin D deficiency among HIV type 1-infected individuals in The Netherlands: effects of antiretroviral therapy. AIDS Res. Hum. Retroviruses 24(11), 1375-1382 (2008).
22. Oyedele T, Adeyemi OM. High prevalence of vitamin D deficiency in HIV-infected adults: What are the future research questions? Curr. HIV/AIDS Rep. 9(1), 1-4 (2012).
23. Wasserman P, Rubin DS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS 24(4), 223-227 (2010).
24. Conrado T, Miranda-Filho Dde B, Bandeira F. [Vitamin D deficiency in HIV-infected individuals: one more risk factor for bone loss and cardiovascular disease?] Arq. Bras. Endocrinol. Metabol. 54(2), 118-122 (2010).
25. Rodríguez M, Daniels B, Gunawardene S, Robbins GK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res. Hum. Retroviruses 25(1), 9-14 (2009).
26. Viard JP, Souberbielle JC, Kirk O, et al.; EuroSIDA Study Group. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS 25(10), 1305-1315 (2011).
27. Frontini M, Nnadi J, Bairu S, Khan T, Chotalia J, Clark R A. Risk factors for suboptimal vitamin D levels among adults with HIV attending an inner-city clinic of New Orleans, Louisiana. J. La State Med. Soc. 164(1), 10-12 (2012).
28. Mehta S, Giovannucci E, Mugusi FM, et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 5(1), e8770 (2010).
29. Crutchley RD, Gathe J Jr, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res. Hum. Retroviruses 28(5), 454-459 (2012).
30. Kim JH, Gandhi V, Psevdos G Jr, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res. Hum. Retroviruses 28(3), 235-241 (2012).
31. Torres C, Sánchez de la Torre M, García- Moruja C, et al. Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV 1 infection and rate of disease progression. Curr. HIV Res. 8(6), 487-492 (2010).
32. Haug CJ, Müller F, Rollag H, Aukrust P, Degré M, Frøland SS. The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency. APMIS 104(7-8), 539-548 (1996).
33. Connor RI, Rigby WF. 1 alpha,25- dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV 1. Biochem. Biophys. Res. Commun. 176(2), 852-859 (1991).
34. Ross AC, McComsey GA. The role of vitamin D deficiency in the pathogenesis of osteoporosis and in the modulation of the immune system in HIV-infected patients. Clin. Rev. Bone Miner. Metabol. 10(4), 277-278 (2012).
35. Girasole G, Wang JM, Pedrazzoni M, et al. Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients. J. Immunol. 145(8), 2459-2464 (1990).
36. Sudfeld CR, Wang M, Aboud S, Giovannucci EL, Mugusi FM, Fawzi WW. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy. PLoS ONE 7(6), e40036 (2012).
37. Kakalia S, Sochett EB, Stephens D, Assor E, Read SE, Bitnun A. Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus. J. Pediatr. 159(6), 951-957 (2011).
38. Bang U, Kolte L, Hitz M, et al. Correlation of increases in 1,25-dihydroxyvitamin D during vitamin D therapy with activation of CD4+ T lymphocytes in HIV 1-infected males. HIV Clin. Trials 13(3), 162-170 (2012).
39. Haug CJ, Aukrust P, Lien E, Müller F, Espevik T, Frøland SS. Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. J. Infect. Dis. 173(1), 259-262 (1996).
40. Eisenhut M. Effect of vitamin D on tuberculosis and HIV replication depends on conversion to calcitriol and concentration. Am. J. Respir. Crit. Care Med. 180(8), 795 (2009).
41. Equils O, Hewison M. A role for vitamin D in placental immunology. J. Infect. Dis. 201(12), 1950-1951 (2010).
42. Yin M, Stein E. The effect of antiretrovirals on vitamin D. Clin. Infect. Dis. 52(3), 406-408 (2011).
43. Bander D, Parczewski M. Osteoporosis and vitamin D deficiency in HIV-infected patients: genetic and classical factors compared to the HIV-associated ones - review. HIV & AIDS Review 11(1), 1-4 (2012).
44. Madeddu G, Spanu A, Solinas P, et al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q. J. Nucl. Med. Mol. Imaging 48(1), 39-48 (2004).
45. Masiá M, Padilla S, Robledano C, López N, Ramos JM, Gutiérrez F. Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res. Hum. Retroviruses 28(3), 242-246 (2012).
46. Ramayo E, González-Moreno MP, Macías J, et al. Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 21(11), 915-921 (2005).
47. O'Brien KO, Razavi M, Henderson RA, Caballero B, Ellis KJ. Bone mineral content in girls perinatally infected with HIV. Am. J. Clin. Nutr. 73(4), 821-826 (2001).
48. Childs K, Welz T, Samarawickrama A, Post FA. Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS 26(3), 253-262 (2012).
49. Focà E, Motta D, Borderi M, et al. Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/ emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect. Dis. 12, 38 (2012).
50. Childs KE, Fishman SL, Constable C, et al. Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res. Hum. Retroviruses 26(8), 855-859 (2010).
51. Havens PL, Stephensen CB, Hazra R, et al.; Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions 063 study team. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin. Infect. Dis. 54(7), 1013-1025 (2012).
52. Etminani-Esfahani M, Khalili H, Jafari S, Abdollahi A, Dashti-Khavidaki S. Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz. BMC Res. Notes 5(1), 204 (2012).
53. Arpadi SM, McMahon DJ, Abrams EJ, et al. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am. J. Clin. Nutr. 95(3), 678-685 (2012).
54. Mondy K, Powderly WG, Claxton SA, et al. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J. Acquir. Immune Defic. Syndr. 38(4), 426-431 (2005).
55. McComsey GA, Kendall MA, Tebas P, et al. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS 21(18), 2473-2482 (2007).
56. Bolland MJ, Grey AB, Horne AM, et al. Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. J. Clin. Endocrinol. Metab. 92(4), 1283-1288 (2007).
57. Bolland MJ, Grey AB, Horne AM, et al. Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months. J. Bone Miner. Res. 23(8), 1304-1308 (2008).
58. Huang J, Meixner L, Fernandez S, McCutchan JA. A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS 23(1), 51-57 (2009).
59. Lin D, Rieder MJ. Interventions for the treatment of decreased bone mineral density associated with HIV infection. Cochrane Database Syst. Rev. 2, CD005645 (2007).
60. Mehta S, Mugusi FM, Spiegelman D, et al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 25(10), 579-585 (2011).
61. Lochner JD, Schneider DJ. The relationship between tuberculosis, vitamin D, potassium and AIDS. A message for South Africa? S. Afr. Med. J. 84(2), 79-82 (1994).
62. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 179(9), 843-850 (2009).
63. Realegeno S, Modlin RL. Shedding light on the vitamin D-tuberculosis-HIV connection. Proc. Natl Acad. Sci. USA 108(47), 18861-18862 (2011).
64. Haug CJ, Müller F, Aukrust P, Frøland SS. Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls. Immunol. Lett. 63(2), 107-112 (1998).
65. Campbell GR, Spector SA. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 8(5), e1002689 (2012).
66. Sroussi HY, Burke-Miller J, French AL, et al. Association among vitamin D, oral candidiasis, and calprotectinemia in HIV. J. Dent. Res. 91(7), 666-670 (2012).
67. Huang JC, Kuo MC, Hwang SJ, Hwang DY, Chen HC. Vitamin D-mediated hypercalcemia as the initial manifestation of pulmonary cryptococcosis in an HIV-uninfected patient. Intern. Med. 51(13), 1793-1796 (2012).
68. Mda S, van Raaij JM, de Villiers FP, MacIntyre UE, Kok FJ. Short-term micronutrient supplementation reduces the duration of pneumonia and diarrheal episodes in HIV-infected children. J. Nutr. 140(5), 969-974 (2010).
69. French AL, Adeyemi OM, Agniel DM, et al. The association of HIV status with bacterial vaginosis and vitamin D in the United States. J. Womens Health (Larchmt) 20(10), 1497-1503 (2011).
70. Mascitelli L, Pezzetta F, Goldstein MR. Cholesterol, vitamin D and cardiovascular prevention in HIV patients treated with antiretroviral therapy. Int. J. Cardiol. 146(3), 441-442 (2011).
71. Choi AI, Lo JC, Mulligan K, et al. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin. Infect. Dis. 52(7), 941-944 (2011).
72. Ross AC, Judd S, Kumari M, et al. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir. Ther. 16(4), 555-563 (2011).
73. Shikuma CM, Seto T, Liang CY, et al. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res. Hum. Retroviruses 28(8), 793-797 (2012).
74. Lai H, Detrick B, Fishman EK, et al. Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J. Investig. Med. 60(5), 801-807 (2012).
75. Lai H, Gerstenblith G, Fishman EK, et al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin. Infect. Dis. 54(12), 1747-1755 (2012).
76. Longenecker CT, Hileman CO, Carman TL, et al. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir. Ther. 17(4), 613-621 (2012).
77. Szep Z, Guaraldi G, Shah SS, et al. Vitamin D deficiency is associated with Type 2 diabetes mellitus in HIV infection. AIDS 25(4), 525-529 (2011); erratum: 25(13), 1682 (2011).
78. van den Bout-van den Beukel CJ, van den Bos M, Oyen WJ, et al. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV 1-infected patients. HIV Med. 9(9), 771-779 (2008).
79. Gharakhanian S, Kotler DP. Diabetes mellitus, HIV infection, and vitamin D: time to act or time to think? AIDS 25(4), 531-533 (2011).
80. Hammond E, McKinnon E, Glendenning P, Williams R, Mallal S, Phillips E. Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clin. Endocrinol. 76(2), 201-206 (2012).
81. Merhi ZO, Seifer DB, Weedon J, et al. Circulating vitamin D correlates with serum antiMüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study. Fertil. Steril. 98(1), 228-234 (2012).
82. Milazzo L, Mazzali C, Bestetti G, et al. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr. HIV Res. 9(3), 186-193 (2011).
83. Estrella MM, Kirk GD, Mehta SH, et al. Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. AIDS 26(3), 295-302 (2012).
84. Adams JS, Fernandez M, Gacad MA, et al. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood 73(1), 235-239 (1989).
85. Lavae-Mokhtari M, Mohammad-Khani S, Schmidt RE, Stoll M. [Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]. Med. Klin. 104(10), 810-813 (2009).
86. Gray JD, Bottomley W, Layton AM, Cotterill JA, Monteiro E. The use of calcipotriol in HIV-related psoriasis. Clin. Exp. Dermatol. 17(5), 342-343 (1992).
87. Hardman KA, Heath DA, Nelson HM. Hypercalcaemia associated with calcipotriol (Dovonex) treatment. BMJ 306(6882), 896 (1993).
88. Finkelstein JL, Mehta S, Duggan CP, et al. Predictors of anaemia and iron deficiency in HIV-infected pregnant women in Tanzania: a potential role for vitamin D and parasitic infections. Public Health Nutr. 15(5), 928-937 (2012).
89. Finkelstein JL, Mehta S, Duggan C, et al. Maternal vitamin D status and child morbidity, anemia, and growth in human immunodeficiency virus-exposed children in Tanzania. Pediatr. Infect. Dis. J. 31(2), 171-175 (2012).
90. Mehta S, Spiegelman D, Aboud S, et al. Lipid-soluble vitamins A, D, and E in HIV-infected pregnant women in Tanzania. Eur. J. Clin. Nutr. 64(8), 808-817 (2010).
91. Siegfried N, Irlam JH, Visser ME, Rollins NN. Micronutrient supplementation in pregnant women with HIV infection. Cochrane. Database. Syst. Rev. 3, CD009755 (2012).
92. Rutstein R, Downes A, Zemel B, Schall J, Stallings V. Vitamin D status in children and young adults with perinatally acquired HIV infection. Clin. Nutr. 30(5), 624-628 (2011).
93. Pasquet A, Viget N, Ajana F, et al. Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? AIDS 25(6), 873-874 (2011).
94. Welz T, Childs K, Post FA. Do nevirapine and efavirenz affect vitamin D homeostasis similarly? AIDS 25(6), 875-876 (2011).
95. Cozzolino M, Vidal M, Arcidiacono MV, Tebas P, Yarasheski KE, Dusso AS. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS 17(4), 513-520 (2003).
96. Fox J, Peters B, Prakash M, Arribas J, Hill A, Moecklinghoff C. Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res. Hum. Retroviruses 27(1), 29-34 (2011).
97. Arpadi SM, McMahon D, Abrams EJ, et al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics 123(1), e121-e126 (2009).
98. Irlam JH, Visser ME, Rollins N, Siegfried N. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst. Rev. 4, CD003650 (2005); update: 12, CD003650 (2010).
99. Ndeezi G, Tylleskär T, Ndugwa CM, Tumwine JK. Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial. J. Int. AIDS Soc. 13, 18 (2010).
100. Spindel SJ, Hamill RJ, Georghiou PR, Lacke CE, Green LK, Mallette LE. Case report: vitamin D-mediated hypercalcemia in fungal infections. Am. J. Med. Sci. 310(2), 71-76 (1995).
101. Ali MY, Gopal KV, Llerena LA, Taylor HC. Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis. Am. J. Med. Sci. 318(6), 419-423 (1999).
102. Tuon FF, Nihei CH, Gryschek RC, Seguro AC. Vitamin D intoxication: a cause of hypocalcaemia and acute renal failure in a HIV patient. Int. J. STD AIDS 19(2), 137-138 (2008).
103. Villamor E. A potential role for vitamin D on HIV infection? Nutr. Rev. 64(5 Pt 1), 226-233 (2006).
104. Spector SA. Vitamin D and HIV: letting the sun shine in. Top. Antivir. Med. 19(1), 6-10 (2011).
105. Lake JE, Adams JS. Vitamin D in HIV-infected patients. Curr. HIV/AIDS Rep. 8(3), 133-141 (2011).
106. Overton ET, Yin MT. The rapidly evolving research on vitamin D among HIV-infected populations. Curr. Infect. Dis. Rep. 13(1), 83-93 (2011).